Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-26 @ 11:00 AM
Ignite Modification Date: 2025-12-26 @ 11:00 AM
NCT ID: NCT03002506
Description: Adverse events were to be reported if reported by the participant, healthcare team member, research team member, or lab documented.
Frequency Threshold: 0
Time Frame: 24 hours
Study: NCT03002506
Study Brief: Pharmacokinetics of Ceftolozane/Tazobactam in Patients With Burns
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Ceftolozane/Tazobactam One dose of 3 grams ceftolozane/tazobactam will be administered to each study participant. Ceftolozane/tazobactam: Single dose of 2 grams/1 gram intravenously administered over 60 minutes. 0 None 0 6 0 6 View
Serious Events(If Any):
Other Events(If Any):